Remove Healthcare Remove Healthcare Professional Remove Patient-Centered Remove Presentation
article thumbnail

Artificial Intelligence in Health Care

Integrated Care News by CFHA

That small win reminded me that artificial intelligence is already shaping the way our patients (and our families) search for health advice. Our Patients Are Already Using AI Many people now ask their first health question to a chatbot rather than to a clinician. Below, I share three reasons why. References Menchaca, J.

article thumbnail

Vaccine Uptake Strategies & Ethical Considerations- Part II

Integrated Care News by CFHA

Availability and Requirements Vaccination programs in communities, including schools, childcare centers, community gathering places, and homes, also successfully improve vaccine uptake, especially for children less likely to access healthcare. Requiring vaccines for school or childcare attendance can also contribute to improving it.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COVID-19 Series (Part Two) with Dr. Laura Bishop

Louisville Lectures

Laura Bishop presents part two of the the COVID-19 Series where she discusses the natural course of disease. She covers practical aspects of evaluating patients including appropriate personal protective equipment (PPE) usage and finishes this segment with clinical exam/laboratory/imaging findings. Arentz M, Yim E, Klaff L, et al.

article thumbnail

Screening for Dementia: A Podcast with Anna Chodos, Joseph Gaugler and Soo Borson

GeriPal

Joseph Gaugler is the Director of the Center for Healthy Aging and Innovation at the University of Minnesota, director of the BOLD Public Health Center of Excellence on Dementia Caregiving, and Editor-in-Chief of the Gerontologist. Who should get it if anyone? What should we use to screen individuals? Is that right, Soo? Joe 01:15 Yes.

Screening 119
article thumbnail

Déjà Vu: OPDP Again Targets Provider Branded Website of Accelerated Approval Drug in Second Untitled Letter of 2025

FDA Law

By Sarah Wicks & Dara Katcher Levy FDAs Office of Prescription Drug Promotion (OPDP) issued its second Untitled Letter of 2025 to Taiho Oncology (Taiho) for a healthcare provider branded website for its drug LYTGOBI (futibatinib). Mirati) about a healthcare professional branded website for KRAZATI (adagrasib).

article thumbnail

Episode 120: Antiracism in Medicine Series Episode 1 – Racism, Police Violence, and Health

The Clinical Problem Solvers

Hardeman on police brutality and a public health agenda 24:00 Understanding this moment (COVID-19 and George Floyd) 29:00 The #SayHerName campaign and police brutality’s effects on women 33:00 Emmett and Mamie Till 44:00 Policing in healthcare settings 54:00 What can we start doing tomorrow?

article thumbnail

Deprescribing Super Special Part II: Podcast with Elizabeth Bayliss, Ariel Green, and Kevin McConeghy

GeriPal

My take home from this is that while the most preferred explanation for deprescribing statins and sedative-hypnotics is one focused on the risk of side effects, we also need to individualize it to the patient and the medication that they are taking. But how to talk to patients about the risk and benefits when starting. Welcome, Ariel.